Clinical Trial Update: Linezolid Tolerance During the BPaL Regimen With Dosage Personalization Based on Therapeutic Drug Monitoring (TDM) During Multidrug-Resistant Tuberculosis Treatment [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating linezolid tolerance with dose personalization guided by therapeutic drug monitoring in the BPaL regimen for multidru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multidrug-resistant Tuberculosis

Drugs mentioned

• Bedaquiline (Sirturo) (bedaquiline)
• Linezolid (Linezolid)
• Pretomanid (pretomanid)

Snippet

Sponsor: Marco Schiuma | Conditions: Linezolid, Tuberculosis Multi Drug Resistant Active | Phase 4 | Status: NOT_YET_RECRUITING